Related Experiment Video
Updated: Jun 24, 2026

Isolation and Kv Channel Recordings in Murine Atrial and Ventricular Cardiomyocytes
Published on: March 12, 2013
Neural KCNQ (Kv7) channels
David A Brown1, Gayle M Passmore
1Department of Pharmacology, University College London, London, UK. d.a.brown@ucl.ac.uk
Kv7 potassium channels (Kv7.2-Kv7.5) regulate neuronal excitability. Drugs targeting these channels, like flupirtine and retigabine, reduce excitability and show therapeutic potential for pain and seizures.
Area of Science:
- Neuroscience
- Molecular Biology
- Pharmacology
Background:
- KCNQ genes encode Kv7 potassium channel subunits, with Kv7.2-Kv7.5 expressed in the nervous system.
- Kv7.2 and Kv7.3 subunits form the M-channel, crucial for regulating neuronal excitability.
- M-channels are inhibited by muscarinic receptors via phospholipase C, impacting neuronal firing patterns.
Purpose of the Study:
- To elucidate the role of Kv7/M-channels in neuronal excitability.
- To investigate the physiological consequences of M-channel modulation in various neuronal systems.
- To explore the therapeutic potential of Kv7 channel modulators in pain and neurological disorders.
Main Methods:
- Analysis of KCNQ gene function and Kv7 subunit expression.
- Electrophysiological studies on neuronal excitability.
- Pharmacological manipulation using M-channel blockers (linopirdine, XE991) and activators (flupirtine, retigabine).
- Investigation of KCNQ2 gene disruption effects.
Main Results:
- M-channel closure by muscarinic receptors increases neuronal excitability in sympathetic, sensory, and hippocampal neurons.
- M-channel blockade facilitates repetitive firing, enhances after-depolarizations, and induces spontaneous firing.
- Kv7 channel activators like flupirtine and retigabine reduce neuronal excitability by shifting voltage gating.
- Flupirtine acts as a central analgesic, while retigabine shows promise as an anticonvulsant and analgesic.
Conclusions:
- Kv7/M-channels are critical regulators of neuronal excitability, with implications for cholinergic signaling and neuronal function.
- Modulation of Kv7 channels offers a promising therapeutic strategy for conditions involving neuronal hyperexcitability, such as pain and epilepsy.
- Kv7 channel activators demonstrate significant potential for treating chronic pain and seizure disorders.
More Related Videos
11:02Exploring Arterial Smooth Muscle Kv7 Potassium Channel Function using Patch Clamp Electrophysiology and Pressure Myography
Published on: September 14, 2012
07:31Profiling Voltage-gated Potassium Channel mRNA Expression in Nigral Neurons using Single-cell RT-PCR Techniques
Published on: September 27, 2011
Related Concept Videos
Voltage-gated Ion Channels
Generally, all voltage-gated ion channels have a 'voltage-sensing domain' that spans the lipid bilayer. The charged residues in the sensor move in response to the membrane potential changes that open the channel allowing ions movement. There are several types of...
Voltage-gated Ion Channels
Generally, all voltage-gated ion channels have a 'voltage-sensing domain' that spans the lipid bilayer. The charged residues in the sensor move in response to the membrane potential changes that open the channel allowing ions movement. There are several types of...
The Role of Ion Channels in Neuronal Computation
Sometimes a single EPSP is strong enough to induce an action potential in the postsynaptic neuron. However, multiple presynaptic inputs must often create EPSPs around the same time for the postsynaptic neuron to be sufficiently depolarized to fire an action potential.
Non-gated Ion Channels
Compared to the gated ion channels, the non-gated channels, also known as leakage or passive channels, have no gating mechanism.
Non-gated Ion Channels
Compared to the gated ion channels, the non-gated channels, also known as leakage or passive channels, have no gating mechanism.
Mechanically-gated Ion Channels